Larry Altstiel, M.D., Ph.D.

EVP, Chief Medical Officer

Dr. Altstiel joined vTv Therapeutics in 2015 as Chief Medical Officer and brings decades of pharmaceutical industry experience and medical expertise including serving in senior research and management roles at Pfizer Inc. and Eli Lilly Company. Most recently, Dr. Altstiel was Chief Executive Officer of Provectra Biotherapeutics where he led the company’s mission in developing gene therapy for neuro-degenerative diseases. Previously, Dr. Altstiel served as Vice President Neuroscience Clinical Development, Neuroscience Therapeutic Area Clinical Lead from 2007-2013. There he also served as Head of the Neuroscience Technical Review Committee that approved clinical research and development programs. Prior to joining Pfizer, Dr. Altstiel held senior research and management roles at Schwarz Biosciences Inc., Eisai Medical Research Inc., Schering-Plough and Eli Lilly and Company, where he was a Senior Clinical Research Physician and Group Leader for Neurodegenerative Diseases Clinical and discovery research for Alzheimer's disease, Parkinson’s disease, and stroke.